We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Expands Regenerative Medicine Portfolio With Rodeo Purchase
Amgen Expands Regenerative Medicine Portfolio With Rodeo Purchase
Amgen is acquiring Seattle, Wash.-based Rodeo Therapeutics in a move to broaden its reach in regenerative medicine, in a deal worth up to $721 million.